BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31337264)

  • 1. Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.
    Chen T; Wang Y; Xu Z; Zou X; Wang P; Ou X; Li Y; Peng T; Chen D; Li M; Cai M
    FASEB J; 2019 Sep; 33(9):10563-10576. PubMed ID: 31337264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
    Liu X; Sadaoka T; Krogmann T; Cohen JI
    J Virol; 2020 May; 94(11):. PubMed ID: 32213613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
    Liu X; Cohen JI
    J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65.
    Cai M; Xiao B; Wang Y; Wang K; Luo W; Fu J; Wang S; Deng S; Li B; Gong L; Zhong J; Hu L; Pan L; Wang L; Liu Y; Huang C; Li X; Zeng Q; Kang H; Li L; Zan J; Peng T; Yang H; Li M
    J Biol Chem; 2023 May; 299(5):104613. PubMed ID: 36931391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.
    Jangra S; Bharti A; Lui WY; Chaudhary V; Botelho MG; Yuen KS; Jin DY
    J Virol; 2021 Sep; 95(20):e0102721. PubMed ID: 34319780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon
    Konishi N; Narita Y; Hijioka F; Masud HMAA; Sato Y; Kimura H; Murata T
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29695622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
    Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
    Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.
    Zhang J; Wang K; Wang S; Zheng C
    J Virol; 2013 Dec; 87(23):12935-48. PubMed ID: 24067962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes Simplex Virus 1 UL2 Inhibits the TNF-α-Mediated NF-κB Activity by Interacting With p65/p50.
    Cai M; Liao Z; Zou X; Xu Z; Wang Y; Li T; Li Y; Ou X; Deng Y; Guo Y; Peng T; Li M
    Front Immunol; 2020; 11():549. PubMed ID: 32477319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.
    Zhang K; Lv DW; Li R
    Virology; 2020 Jan; 540():75-87. PubMed ID: 31743858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.
    Campbell AM; De La Cruz-Herrera CF; Marcon E; Greenblatt J; Frappier L
    PLoS Pathog; 2022 Jan; 18(1):e1010235. PubMed ID: 35007297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.
    Sato Y; Yaguchi M; Okuno Y; Ishimaru H; Sagou K; Ozaki S; Suzuki T; Inagaki T; Umeda M; Watanabe T; Fujimuro M; Murata T; Kimura H
    Cell Commun Signal; 2022 Jun; 20(1):95. PubMed ID: 35729616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation.
    Wang Y; Xiang GS; Kourouma F; Umar S
    Br J Pharmacol; 2006 Jul; 148(6):814-24. PubMed ID: 16751795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
    Kurokawa M; Ghosh SK; Ramos JC; Mian AM; Toomey NL; Cabral L; Whitby D; Barber GN; Dittmer DP; Harrington WJ
    Blood; 2005 Jul; 106(1):235-40. PubMed ID: 15790788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus Envelope Glycoprotein gp110 Inhibits IKKi-Mediated Activation of NF-κB and Promotes the Degradation of β-Catenin.
    Guo Y; Pan L; Wang L; Wang S; Fu J; Luo W; Wang K; Li X; Huang C; Liu Y; Kang H; Zeng Q; Fu X; Huang Z; Li W; He Y; Li L; Peng T; Yang H; Li M; Xiao B; Cai M
    Microbiol Spectr; 2023 Jun; 11(3):e0032623. PubMed ID: 37022262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
    Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
    Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.